JAZZ Annual Non Current Assets
$7.96 B
-$271.18 M-3.30%
31 December 2023
Summary:
As of January 22, 2025, JAZZ annual long term assets is $7.96 billion, with the most recent change of -$271.18 million (-3.30%) on December 31, 2023. During the last 3 years, it has risen by +$4.26 billion (+115.29%). JAZZ annual non current assets is now -17.85% below its all-time high of $9.69 billion, reached on December 31, 2021.JAZZ Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Quarterly Non Current Assets
$7.87 B
+$185.09 M+2.41%
30 September 2024
Summary:
As of January 22, 2025, JAZZ quarterly long term assets is $7.87 billion, with the most recent change of +$185.09 million (+2.41%) on September 30, 2024. Over the past year, it has dropped by -$93.02 million (-1.17%). JAZZ quarterly non current assets is now -23.33% below its all-time high of $10.26 billion, reached on June 30, 2021.JAZZ Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.3% | -1.2% |
| 3 y3 years | +115.3% | -1.2% |
| 5 y5 years | +100.5% | -1.2% |
JAZZ Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.9% | at low | -18.8% | +2.4% |
| 5 y | 5-year | -17.9% | +115.3% | -23.3% | +119.1% |
| alltime | all time | -17.9% | >+9999.0% | -23.3% | >+9999.0% |
Jazz Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.87 B(+2.4%) |
| June 2024 | - | $7.68 B(-1.4%) |
| Mar 2024 | - | $7.79 B(-2.1%) |
| Dec 2023 | $3.44 B(+31.8%) | $7.96 B(-0.0%) |
| Sept 2023 | - | $7.96 B(-3.5%) |
| June 2023 | - | $8.25 B(-0.1%) |
| Mar 2023 | - | $8.26 B(+0.4%) |
| Dec 2022 | $2.61 B(-0.2%) | $8.23 B(+5.3%) |
| Sept 2022 | - | $7.81 B(-9.2%) |
| June 2022 | - | $8.61 B(-7.1%) |
| Mar 2022 | - | $9.27 B(-4.3%) |
| Dec 2021 | $2.61 B(-8.0%) | $9.69 B(-1.7%) |
| Sept 2021 | - | $9.85 B(-4.0%) |
| June 2021 | - | $10.26 B(+185.8%) |
| Mar 2021 | - | $3.59 B(-2.9%) |
| Dec 2020 | $2.84 B(+74.2%) | $3.70 B(-1.1%) |
| Sept 2020 | - | $3.74 B(-0.7%) |
| June 2020 | - | $3.76 B(+1.8%) |
| Mar 2020 | - | $3.70 B(-5.4%) |
| Dec 2019 | $1.63 B(+32.1%) | $3.91 B(-2.5%) |
| Sept 2019 | - | $4.01 B(-2.7%) |
| June 2019 | - | $4.12 B(+3.6%) |
| Mar 2019 | - | $3.97 B(+0.1%) |
| Dec 2018 | $1.23 B(+27.4%) | $3.97 B(-1.3%) |
| Sept 2018 | - | $4.02 B(-0.5%) |
| June 2018 | - | $4.04 B(-2.9%) |
| Mar 2018 | - | $4.16 B(+0.1%) |
| Dec 2017 | $968.28 M(+29.4%) | $4.16 B(-0.3%) |
| Sept 2017 | - | $4.17 B(+0.6%) |
| June 2017 | - | $4.14 B(+1.9%) |
| Mar 2017 | - | $4.06 B(+0.3%) |
| Dec 2016 | $748.07 M(-40.5%) | $4.05 B(-3.2%) |
| Sept 2016 | - | $4.19 B(+88.8%) |
| June 2016 | - | $2.22 B(-2.1%) |
| Mar 2016 | - | $2.26 B(+9.1%) |
| Dec 2015 | $1.26 B | $2.07 B(-3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $2.15 B(+0.0%) |
| June 2015 | - | $2.15 B(+0.6%) |
| Mar 2015 | - | $2.13 B(-8.1%) |
| Dec 2014 | $1.02 B(+17.5%) | $2.32 B(-5.9%) |
| Sept 2014 | - | $2.47 B(-5.4%) |
| June 2014 | - | $2.61 B(-2.5%) |
| Mar 2014 | - | $2.68 B(+95.0%) |
| Dec 2013 | $864.62 M(+56.8%) | $1.37 B(-0.1%) |
| Sept 2013 | - | $1.38 B(+1.2%) |
| June 2013 | - | $1.36 B(-0.2%) |
| Mar 2013 | - | $1.36 B(-3.7%) |
| Dec 2012 | $551.57 M(+177.0%) | $1.41 B(+5.5%) |
| Sept 2012 | - | $1.34 B(-4.0%) |
| June 2012 | - | $1.40 B(+145.9%) |
| Mar 2012 | - | $568.22 M(+943.7%) |
| Dec 2011 | $199.13 M(+167.4%) | $54.44 M(-2.2%) |
| Sept 2011 | - | $55.67 M(-2.9%) |
| June 2011 | - | $57.32 M(-3.4%) |
| Mar 2011 | - | $59.34 M(-3.2%) |
| Dec 2010 | $74.46 M(+101.5%) | $61.27 M(-6.0%) |
| June 2010 | - | $65.18 M(-4.1%) |
| Mar 2010 | - | $67.96 M(-3.5%) |
| Dec 2009 | $36.95 M(-16.0%) | $70.44 M(-3.5%) |
| Sept 2009 | - | $73.03 M(-3.7%) |
| June 2009 | - | $75.85 M(-0.7%) |
| Mar 2009 | - | $76.39 M(+3.9%) |
| Dec 2008 | $44.00 M(-62.1%) | $73.50 M(-33.2%) |
| Sept 2008 | - | $110.09 M(-5.4%) |
| June 2008 | - | $116.39 M(-2.8%) |
| Mar 2008 | - | $119.77 M(+31.0%) |
| Dec 2007 | $116.09 M(+26.8%) | $91.46 M(-19.6%) |
| Sept 2007 | - | $113.79 M(-1.7%) |
| June 2007 | - | $115.72 M(-2.5%) |
| Mar 2007 | - | $118.64 M(-3.5%) |
| Dec 2006 | $91.56 M(+191.8%) | $123.01 M(-7.8%) |
| Dec 2005 | $31.38 M | $133.40 M |
FAQ
- What is Jazz Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual non current assets year-on-year change?
- What is Jazz Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly non current assets year-on-year change?
What is Jazz Pharmaceuticals annual long term assets?
The current annual non current assets of JAZZ is $7.96 B
What is the all time high annual non current assets for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual long term assets is $9.69 B
What is Jazz Pharmaceuticals annual non current assets year-on-year change?
Over the past year, JAZZ annual long term assets has changed by -$271.18 M (-3.30%)
What is Jazz Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of JAZZ is $7.87 B
What is the all time high quarterly non current assets for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly long term assets is $10.26 B
What is Jazz Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, JAZZ quarterly long term assets has changed by -$93.02 M (-1.17%)